Ashani T Weeraratna

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    R01, Recurrence and Resistance in the Aging Melanoma Microenvironment, R01CA298306, 2025–2030, 18 Jun 2026

  • National Cancer Institute

    P01, Targeted Therapies in Melanoma, P01CA114046, 2008–2025, 6 Sept 2023

  • National Cancer Institute

    R01, An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin, R01CA232256, 2019–2025, 24 Feb 2023

Sources: reporter.nih.gov